To complement the many findings already reported, RMP serum levels were determined in 60 patients. Determinations were done by the microbiological method of agar diffusion (test organism, Sarcina lutea); and results were assessed by means of standard curves. The patients were receiving long-term therapy with RMP in combination with other tuberculostatic agents. Serum levels were determined before, and 90 min and 3 h after 600 mg of RMP were given on an empty stomach. The absolute serum concentrations measured, the times when peak levels were reached, and the considerable individual variations in some cases, agreed largely with the results of other investigations using comparable methods. Long-term administration of RMP and the combination with other tuberculostatic agents did not affect the serum levels to any notable extent, though the group of patients given RMP therapy for more than 6 months did show definitely the highest serum concentrations. On the other hand it should be stressed that a single total dose every 24 hours is only the best method in the treatment of tuberculosis, and not of other bacterial infections. With the latter, the dose should be preferably divided into two per day, because nonspecific organisms causing infections produce new generations at about 4 times the rate shown by Mycobacterium tuberculosis. Experimental studies seem to indicate that intermittent therapy with high doses promises much for the treatment of tuberculosis, but this still requires further clinical investigation.

Keywords:
Serum levels, Rifampicin
This content is only available via PDF.
© 1971 S. Karger AG, Basel
1971
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.